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Summary  Adult  patients  with  congenital  heart  disease  (ACHD)  represent  a  growing  population
due to  progress  in  management.  Surgical  procedures  generally  fall  short  of  restoring  entirely
normal anatomical  and  functional  relations.  Further  procedures  can  be  needed  and  lifelong
follow-up  is  required.  The  right  ventricle  (RV)  plays  an  important  role  in  congenital  heart  dis-
ease and  cardiac  magnetic  resonance  (CMR)  imaging  has  become  the  imaging  method  of  choice
for its  assessment.  CMR  can  provide  relatively  accurate  measurements  of  RV  volume  and  func-
tion, and  arterial  ﬂow,  with  additional  anatomical  information  provided  by  three-dimensional
contrast angiography  and  late  gadolinium  imaging  of  ﬁbrosis.  Here  we  focus  our  review  on  three
categories  of  ACHD  in  which  evaluation  of  the  RV  is  important:  repaired  tetralogy  of  Fallot,  the
systemic RV  and  Ebstein  anomaly.  We  demonstrate  how  CMR  contributes  to  decision-making
regarding the  types  and  timings  of  interventions.  A  dedicated  CMR  service  should  be  regarded
entre  specializing  in  the  care  of  ACHD  patients.as a  necessary  facility  of  a  c
© 2012  Published  by  Elsevier  Masson  SAS.
Abbreviations: ACHD, adult congenital heart disease; CCTGA, congenitally corrected transposition of the great arteries; rTOF,
repaired tetralogy of Fallot; RV, right ventricle/ventricular; RVOT, right ventricular outﬂow tract; TGA, transposition of the great arteries;
TOF, tetralogy of Fallot.
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Résumé  Les  adultes  atteints  de  cardiopathies  congénitales  représentent  une  population  de
patients qui  augmente  grâce  aux  progrès  dans  leur  prise  en  charge.  Les  interventions  chirurgi-
cales ne  peuvent  aboutir  à  un  cœur  complètement  normal  dans  son  anatomie  et  sa  fonction.
D’autres interventions  peuvent  s’avérer  nécessaires  et  un  suivi  à  vie  est  requis.  Le  ventricule
droit (VD)  a  un  rôle  important  dans  les  cardiopathies  congénitales  et  l’imagerie  par  résonance
magnétique  (IRM)  est  la  méthode  de  choix  pour  son  évaluation.  Elle  permet  d’estimer  de
fac¸on relativement  rigoureuse  le  volume  et  la  fonction  du  VD,  ainsi  que  la  mesure  des  ﬂux
artériels.  Elle  permet  également  d’apporter  des  informations  complémentaires  anatomiques
par l’angiographie  3D  et  de  caractérisation  tissulaire  par  la  mise  en  évidence  de  ﬁbrose.  Nous
concentrons  cette  revue  sur  trois  catégories  de  pathologie  pour  lesquelles  l’évaluation  du  VD
est essentielle  :  la  tetralogy  de  Fallot  réparée,  le  VD  en  position  systémique  et  l’anomalie
d’Ebstein.  Nous  montrons  comment  l’IRM  intervient  dans  la  prise  en  charge  décisionnelle  pour
le type  et  le  timing  d’intervention.  Un  service  d’imagerie  dédié  est  souhaitable  dans  les  centres
spécialisés  dans  la  prise  en  charge  des  patients  atteints  de  cardiopathie  congénitale.
asson  SAS.
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Table  1  Structural  abnormalities  encountered  after
tetralogy  of  Fallot  repair.
Secondary  to  surgical  repair
Pulmonary  regurgitation
RVOT  scar
Ventricular  septal  defect  patch
Residual  or  recurrent  lesion
RVOT  obstruction
Branch  pulmonary  artery  stenosis
Ventricular  septal  defect
Atrial  septal  defect
Acquired  lesion
Tricuspid  regurgitation
RVOT  aneurysm
Aortic  root  dilatation
Aortic  regurgitation
Left  ventricle  dysfunction
Associated  anomalies
Systemic-to-pulmonary  artery  collateral
Aortic  branch  pattern
RVOT: right ventricular outﬂow tract.
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ackground
ongenital  heart  disease  occurs  in  about  six  to  eight  of
000  live  births  [1,2]. Progresses  in  paediatric  cardiology  and
ardiac  surgery  have  revolutionized  patients  management,
llowing  most  affected  children  to  survive  into  adulthood.
owever,  surgical  procedures  generally  fall  short  of  restoring
ntirely  normal  anatomical  and  functional  relations.  Most
atients  need  lifelong  follow-up  and  many  require  further
ntervention.  The  need  to  understand  and  manage  appro-
riately  the  growing  population  with  adult  congenital  heart
isease  (ACHD)  or  grown-up  congenital  heart  disease  has  led
o  an  expanding  cardiological  subspecialty  in  which  imaging
lays  a  key  role.
In  a  number  of  conditions,  the  right  ventricle  (RV)  is  prone
o  dilatation  and  arrhythmia  and  it  has  received  increasing
ttention  in  recent  decades  [3].  Two-dimensional  echocar-
iography  is  the  ﬁrst-line  cardiovascular  imaging  modality
n  ACHD,  but  RV  volumetric  and  functional  assessments
emain  challenging  due  to  the  asymmetric  shape,  trabecu-
ated  structure  and  the  particular  combination  of  long-  and
hort-axis  functions  of  the  RV  [4].  Cardiovascular  magnetic
esonance  (CMR)  imaging  allows  a  segmental  analysis  and
as  gained  importance  in  the  measurement  and  visualiza-
ion  of  RV  volume  and  function  [5,6]. RV  function  and  volume
valuation  is  of  importance  in  most  repaired  or  unrepaired
CHDs,  such  as  atrial  septal  defect,  pulmonary  atresia  with
ntact  ventricular  septum,  double  outlet  RV,  tetralogy  of
allot  (TOF),  systemic  RV  and  Ebstein  anomaly.  Repaired
ouble  outlet  RV  with  subaortic  ventricular  septal  defect
nd  subpulmonary  stenosis  can  be  integrated  into  the  sec-
ion  covering  analysis  of  TOF.  Finally,  CMR  contributes  to
ecision-making  regarding  the  types  and  timings  of  inter-
entions.
Here  we  will  focus  on  three  categories  of  ACHD  in  which
V  evaluation  by  CMR  is  crucial  in  clinical  decision-making:
epaired  TOF  (rTOF),  the  systemic  RV  and  Ebstein  anomaly.epaired tetralogy of Fallot
n  1945,  Blalock  and  Taussig  described  the  palliation  of  TOF
y  means  of  a  systemic-to-pulmonary  arterial  shunt.  Lillehi
T
s
(
at  al.  reported  the  ﬁrst  open-heart  anatomical  repair  of
OF  in  1954  [7,8]  (Fig.1-1  and  1-2).  Since  then,  patient
anagement  has  improved  dramatically,  with  early  surgical
ortality  decreasing  from  50%  to  less  than  2%  [9,10], so  that
0%  of  the  operated  patients  will  survive  at  least  the  ﬁrst
wo  decades  of  life  [10]. As  a  result,  the  number  of  patients
ith  rTOF  is  growing,  and  more  and  more  investigations  by
MR  are  requested.
ight ventricular volume and pulmonary
egurgitationhe  surgical  repair  consists  of  ventricular  septal  defect  clo-
ure  with  enlargement  of  the  right  ventricular  outﬂow  tract
RVOT)  by  patch  insertion.  The  abnormalities  encountered
re  summarized  in  Table  1.  The  most  frequent  residual
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Figure 1. 1-1: features of repaired tetralogy of Fallot in a 39-year-old patient. Stacks of short-axis views of the ventricles for volume and
function measurements; 1-2: features of repaired tetralogy of Fallot in a 39-year-old patient. A. Four-chamber view showing a moderately
dilated and hypertrophied (arrows) right ventricle (RV). B. Transaxial view of the pulmonary arteries in their proximal course. C. Mild late
gadolinium enhancement (arrow) at patch insertion level. D. Right ventricular outﬂow track cine imaging showing the thin infundibular wall
(pulmonary regurgitation measured by cardiac magnetic resonance through-plane velocity mapping). E. Velocity mapping through a plane
w, di
; LV:
i
r
p
stransecting the main pulmonary artery (MPA). F. Systolic forward ﬂo
atrial systole. Ao: aorta; LA: left atrium; LPA: left pulmonary artery
lesion  is  free  pulmonary  regurgitation  leading  to  RV  dilata-
tion,  which  is  well  tolerated  during  infancy  and  childhood.
The  RV  compensatory  mechanisms  tend  to  fail  during  the
third  decade  and  after,  predisposing  to  arrhythmias,  exer-
cise  intolerance,  heart  failure  and  death  [11,12].  Severe
chronic  pulmonary  regurgitation  has  been  reported  to  be  the
main  cause  of  RV  dilatation  and  arrhythmias.  The  treatment
is  pulmonary  valve  replacement,  but  the  optimal  timing
w
o
aastolic reversed ﬂow and late diastolic forward ﬂow at the time of
 left ventricle; RA: right atrium, RPA: right pulmonary artery.
s still  under  debate  [13,14].  Criteria  for  pulmonary  valve
eplacement  in  rTOF  patients  include  moderate  or  severe
ulmonary  regurgitation  (regurgitation  fraction  ≥  25%),  as
ummarized  in  Table  2.
CMR  has  become  the  imaging  method  of  choice  in  patients
ith  rTOF  [15—17]. It  provides  quantitative  assessment
f  left  ventricular  and  RV  volume,  mass,  stroke  volume
nd  ejection  fraction  (Fig.  1-1).  Several  aspects  of  the  RV
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Table  2  Summary  of  indications  for  pulmonary  valve  replacement  in  repaired  tetralogy  of  Fallot  patients  [37].
Asymptomatic  patients  with  two  or  more  of  the  following  criteria
RV  end-diastolic  volume  index  >  150  mL/m2 or  Z-score  >  4  (in  patients  whose  body
surface  area  falls  outside  published  normal  data,  RV/LV  end-diastolic  volume  ratio  >  2)
RV  end-systolic  volume  index  >  80  mL/m2
RV  ejection  fraction  <  47%
LV  ejection  fraction  <  55%
Large  RVOT  aneurysm
QRS  duration  >  140  ms
Sustained  tachyarrhythmia  related  to  right  heart  volume  load
Other  haemodynamically  signiﬁcant  abnormalities
RVOT  obstruction  with  RV  systolic  pressure  ≥ 2⁄3 systemic
Severe  branch  pulmonary  artery  stenosis  (<  30%  ﬂow  to  affected  lung)  not  amenable
to  transcatheter  therapy
At  least  moderate  tricuspid  regurgitation
Left-to-right  shunt  from  residual  atrial  or  ventricular  septal  defects  with
pulmonary-to-systemic  ﬂow  ratio  ≥  1.5
Severe  aortic  regurgitation
Severe  aortic  dilatation  (diameter  ≥  5  cm)
Symptomatic  patients
Symptoms  and  signs  attributable  to  severe  RV  volume  load  documented  by  CMR  or
alternative  imaging  modality,  fulﬁlling  at  least  one  of  the  quantitative  criteria  detailed
above.  Examples  of  symptoms  and  signs  include
Exercise  intolerance  not  explained  by  extracardiac  causes  (e.g.  lung  disease,
musculoskeletal  anomalies,  genetic  anomalies,  obesity),  with  documentation  by  exercise
testing  with  metabolic  cart  (≤  70%  predicted  peak  VO2 for  age  and  sex  not  explained  by
chronotropic  incompetence)
Signs  and  symptoms  of  heart  failure  (e.g.  dyspnoea  with  mild  effort  or  at  rest  not
explained  by  extracardiac  causes,  peripheral  oedema)
Syncope  attributable  to  arrhythmia
Special  considerations
Due  to  higher  risk  of  adverse  clinical  outcomes  in  patients  who  underwent  TOF  repair
at  age  ≥  3  years  [15], PVR  may  be  considered  if  the  patient  fulﬁls  at  least  one  of  the
quantitative  criteria  in  section  I
Women  with  severe  PR  and  RV  dilatation  and/or  dysfunction  may  be  at  risk  of
pregnancy-related  complications  [38]. Although  no  evidence  is  available  to  support
beneﬁt  from  prepregnancy  PVR,  the  procedure  may  be  considered  if  the  patient  fulﬁls  at
least  one  of  the  quantitative  criteria  in  section  I
CMR: cardiac magnetic resonance imaging; LV: left ventricle; PR: pulmonary regurgitation: PVR: pulmonary valve replacement; RV: right
ventricle; RVOT: right ventricular outﬂow tract; TOF: tetralogy of Fallot.
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Cresent  challenges  for  reproducible  volumetric  measure-
ent  by  CMR.  Different  software  packages  are  available,
ut  there  is  not  yet  a  consensus  as  to  which  is  preferable.
he  free  wall  and  apical  regions  of  the  RV  are  normally
xtensively  trabeculated,  even  more  with  hypertrophy.  A
ecision  has  to  be  made  about  whether  to  include  or  exclude
s  cavity  volume  the  blood  signal  among  the  trabecula-
ions.  Smooth  tracing  outside  the  trabeculations  and  inside
he  compact  layer  is  probably  the  most  reproducible,  par-
icularly  at  end-diastole,  but  is  not  necessarily  the  most
ccurate,  especially  in  the  presence  of  RV  hypertrophy.
he  long-axis  displacement  of  the  base  of  the  RV  is  usually
reater  than  that  of  the  left  ventricle  and  it  is  important  to
nclude  this  basal  region  when  locating  the  ﬁrst  short-axis
lice  at  end-diastole.  After  r  TOF,  any  thin-walled  akinetic
egion  of  the  RVOT  should  be  included  in  the  RV  volume,  up
o
(
so  the  level  of  the  pulmonary  valve  annulus.  Whichever  soft-
are  or  tracing  method  is  used,  it  is  important  to  maintain
onsistent  methods,  with  a  view  to  longitudinal  compar-
son  between  studies  [5].  CMR  has  been  found  to  give
ood  reproducibility  in  rTOF,  with  intraclass  correlations  of
.966  for  RV  end-diastolic  volume,  0.932  for  RV  end-systolic
olume,  0.817  for  RV  ejection  fraction  and  0.831  for  RV
ass  [17].
CMR  phase  contrast  ﬂow  velocity  mapping  can  quantify
he  pulmonary  regurgitant  fraction  (Fig.  1-2); it  can  also
uantify  relative  ﬂow  volumes  through  the  right  and  left  pul-
onary  artery  branches,  which  can  be  further  visualized  by
MR  cine  imaging  and  contrast  angiography.  In  the  presence
f  unilateral  pulmonary  artery  stenosis,  a  preferential  ﬂow
more  than  2:1)  to  the  unaffected  side  may  be  considered
igniﬁcant  [18].
CMR  assessment  of  the  right  ventricle  in  congenital  heart  disease  609
Figure 2. Features of Ebstein anomaly in an unoperated 70-year-old patient shown by cardiac magnetic resonance. Four-chamber (A) and
oblique coronal cines (B) show the atrialized part of the right ventricle (ARV) relative to its functional part (RV). The double arrows indicate
the extent of apical displacement of the septal and inferior insertions of the tricuspid valve. C. Short-axis view of the displaced tricuspid
valve with a central failure of coaptation and tricuspid regurgitation (TR). D. Flow (white) through a velocity mapping plane located to
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vtransect the regurgitant jet; the regurgitant area is about 1.2 cm2 w
ventricle; RA: right atrium.
Right ventricular outﬂow tract
CMR  may  contribute  to  the  stratiﬁcation  of  risk  (Fig.  1-2).
The  presence  of  RVOT  aneurysm  or  akinesia  [18], and  the
presence  of  ﬁbrosis  in  regions  outside  those  of  direct  surgi-
cal  intervention  was  demonstrated  by  CMR  late  gadolinium
enhancement  [19]  and  was  found  to  correlate  with  adverse
clinical  events.  CMR  angiography  can  be  useful  for  providing
three-dimensional  visualization  of  a  complex  RVOT.  Finally,
CMR  can  detect  other  residual  lesions,  such  as  atrial  or
ventricular  septal  defect,  quantifying  the  associated  shunt
by  measurement  of  the  pulmonary-to-ascending  aortic  ﬂow
ratio.  CMR  can  also  provide  information  about  the  severity
of  tricuspid  regurgitation.  Abnormal  aortic  branch  pattern,
which  is  frequently  associated  with  conotruncal  abnormal-
ities  and  aortic  dilatation  and  regurgitation,  can  also  be
studied.
Ebstein anomalyEbstein  anomaly  is  an  uncommon  congenital  malformation
involving  failure  in  the  delamination  of  the  tricuspid  valve
from  the  septal  and  inferior  walls  of  the  RV  (Fig.  2).  The
inferior  parts  of  the  septal  and  mural  leaﬂets  of  the  tricuspid
t
t
g
r regurgitant fraction of ∼50% in this case. LA: left atrium; LV: left
alve  can  therefore  appear  displaced  towards  the  apex,  with
trialization  of  the  base  of  the  RV.  The  functional  part  of
he  RV  then  consists  mainly  of  the  apical  and  outlet  por-
ions.
In  severe  cases,  the  tricuspid  valve  plane  appears
otated,  orientated  in  an  almost  horizontal  plane  beneath
 dilated  RVOT.  Moderate  or  severe  tricuspid  regurgitation
s  common.  The  anomaly  can  also  include  a spectrum  and
bnormalities  of  the  RVOT,  such  as  pulmonary  valve  or  pul-
onary  branch  stenosis.
The  functional  RV  tends  to  show  progressive  dilatation
nd  dysfunction  as  tricuspid  regurgitation  increases  [20].
MR  can  provide  useful  information  for  the  surgeon.  The
ural  leaﬂet  can  be  more  fully  visualized  than  by  echocar-
iography  [21]  and  the  severity  of  regurgitation  assessed
5,6].  Stacks  of  transaxial  and  short-axis  cines  and  four-
hamber  and  oblique  coronal  (or  RV  vertical  long-axis)  cines
how  the  displacement  of  the  inferior  insertion  of  the  tri-
uspid  valve.  The  severity  of  tricuspid  regurgitation  can
e  assessed  using  through-plane  CMR  velocity  mapping,  the
elocity  encoding  range  typically  set  at  250  cm/s,  to  depict
he  cross  section  of  the  regurgitant  stream  through  a  plane
ransecting  the  jet  on  the  atrial  side  of  the  defect.  A  regur-
itant  jet  cross-section  of  6  ×  6  mm  or  more,  reﬂecting  the
egurgitant  defect,  can  be  regarded  as  severe.  An  atrial
610  B.  Bonello,  P.J.  Kilner
Figure 3. 3-1: cardiac magnetic resonance features of the systemic right ventricle (RV). Transposition of the great arteries repaired by
Mustard operation in a 34-year-old patient. A. The pulmonary venous pathway (PVP) drains via a relatively right subsided atrial pathway (A
and D) connected to the right-sided RV, which is hypertrophied and connected to the aorta (Ao). B. Both outﬂow tracks lie parallel to one
another. C. The superior vena cava (SVC) and inferior vena cava (IVC) each drain via channels to the left of the bafﬂe to the left-sided left
ventricle (LV), which is connected to the pulmonary artery (PA). D. Chamber view of the PVP draining to the right-sided atrium connected
to a hypertrophied systemic RV (B); 3-2: cardiac magnetic resonance features of the systemic right ventricle (RV). Atrioventricular and
ventriculoarterial discordance (A and B) in an unoperated 45-year-old patient. A. The morphologically RV is hypertrophied and located to
the patient’s left. The septal insertion of the tricuspid valve (Tri) is apically displaced relative to that of the mitral valve (Mi). B. The two
o
s
utﬂow tracts lie parallel to one another (B). C. In the mid short-axis imag
eptal aspect. Ao: aorta; LA: left atrium; PA: pulmonary artery; RA: righe, the left ventricle (LV) cavity has the smoother, less trabeculated
t atrium.
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cCMR  assessment  of  the  right  ventricle  in  congenital  heart  di
septal  defect  can  be  present  in  about  50%  of  adult  Ebstein
patients,  possibly  due  to  the  gaping  of  a  patent  foramen
ovale,  and  should  be  sought  by  a  CMR  atrial  short-axis  cine
stack.
As  in  other  congenital  heart  disease,  decline  in  exercise
capacity  may  be  taken  as  one  of  the  relative  indications  for
surgery,  but  outcomes  may  be  better  if  surgery  is  performed
before  the  heart  dilates  and  the  clinical  status  deteriorates
[22].
The  cardiothoracic  ratio  measured  on  a  chest  X-ray
reﬂects  RV  dilatation  and  has  been  taken  as  a  guide  to  the
need  for  surgery,  but  CMR  may  now  provide  more  compre-
hensive  assessments  of  RV  and  tricuspid  valve  function  in
Ebstein  anomaly  [19,20].
However,  it  may  not  be  easy  to  delineate  the  functional
from  the  atrialized  RV  from  short-axis  volumetric  measure-
ments  alone.  Yalonetsky  et  al.  found  better  reproducibility
with  transaxial  imaging  of  the  RV,  in  terms  of  both  intra-
and  interobserver  quantiﬁcation  in  patients  with  the  Ebstein
anomaly  [23]  and  correlation  between  RV  atrialized  volume
and  exercise  capacity  [24].
Systemic right ventricle
Systemic  RV  in  adulthood  falls  mainly  into  two  categories
(Fig.  3-1  and  3-2):  transposition  of  the  great  arteries  (TGA)
unrepaired  or  repaired  by  atrial  switch  (Fig.  3-1);  and
congenitally  corrected  transposition  of  the  great  arteries
(CCTGA),  meaning  discordant  atrioventricular  and  ventricu-
loarterial  connections  (Fig.  3-2).
The  systemic  RV  and  its  tricuspid  valve  are  exposed  to
systemic  arterial  afterload.  In  CCTGA,  there  can  also  be  an
Ebstein-like  anomaly  of  the  tricuspid  valve.  The  RV  adapts  by
hypertrophy,  but  does  not  seem  ideally  adapted  to  deliver
systemic  pressure  lifelong.  Systemic  RV  failure  and  tricus-
pid  regurgitation  tend  to  develop  in  the  third  decade  of
life  [25—28]. Prieto  found  that  30%  of  CCTGA  patients  had
signiﬁcant  RV  failure  after  20  years  of  follow-up,  while
more  than  40%  developed  severe  tricuspid  regurgitation;
26%  died  or  required  cardiac  transplantation  at  an  average
age  of  25  years  [29]. Subclinical  RV  dysfunction  precedes
the  development  of  symptomatic  heart  failure  [27,30—33]
and  worsens  outcomes  after  tricuspid  valve  replacement
[26].  CMR  is  the  gold  standard  for  systemic  RV  evaluation
[6].  Which  ventricle  is  morphologically  ‘‘right’’  and  which
is  ‘‘left’’  can  be  determined  by  the  presence  of  multi-
ple  coarse  trabeculations,  including  the  moderator  band,
on  the  RV  side  of  the  septum.  Each  atrioventricular  valve
and  ventriculoarterial  connection  should  be  visualized  by
appropriately  aligned  views.  The  choice  of  method  for  RV
cavity  delineation  for  volume  calculation  is  challenging,
but  delineation  immediately  outside  the  trabeculations  may
give  more  reproducible  measurements  [3].  CMR  has  demon-
strated  good  correlation  between  RV  function  and  clinical
status  [31,34].  Furthermore,  the  presence  of  ﬁbrosis  as
detected  by  late  gadolinium  enhancement  is  associated  with
adverse  outcomes  [31,35].For  patients  with  TGA  and  atrial  switch,  CMR  can  assess
the  atrial  pathways  as  well.  Cines  and  velocity  maps
can  be  aligned  with  respect  to  systemic  and  pulmonary
venous  atrial  pathways  [36]. Comprehensive  coverage  can,
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owever,  be  achieved  using  a  stack  of  contiguous  transax-
al  or  coronal  cines  or  a  three-dimensional  SSFP  sequence.
afﬂe-leaks  may  not  be  easy  to  identify  by  CMR,  the  suture
ine  being  long  and  tortuous.  The  measurement  of  pulmonary
elative  to  aortic  ﬂow  (Qp:Qs)  may  be  useful,  and  any  incom-
etence  of  the  tricuspid  valve  into  the  systemic  RV  needs  to
e  evaluated.
imitations
he  availability  of  CMR  may  still  be  limited,  in  part  due  to
he  cost  of  purchasing  the  equipment  and  the  time  needed
or  acquisition  and  analysis  of  images.
Claustrophobia  is  occasionally  problematic.  Anxiolytics
an  be  considered  in  certain  cases.  Patient  compliance  is
mportant  for  breath-hold  acquisitions,  which  can  present
roblems  in  patients  with  cognitive  or  behavioural  disorders.
CMR  image  quality  and  measurement  accuracy  may  be
ompromised  by  arrhythmias,  although  more  rapid  acquisi-
ions  may  help  to  minimize  the  problem.
Patients  with  a  pacemaker  or  implantable  cardio-
eﬁbrillator  should  not  approach  the  magnet  because  of
he  risk  of  device  dysfunction  and  possible  heating  or  volt-
ge  effects  when  wires  are  in  the  magnet  during  imaging.
urther  studies  are  required  to  evaluate  the  risk  with  new
evices.  Metallic  objects  such  as  wires,  clips,  stents,  occlu-
ion  devices  and  recent  prosthetic  valves  within  the  chest
re  safe  in  a  1.5T  magnet,  causing  only  local  image  arte-
act.
Safety  information  relating  to  the  implant  should,  how-
ver,  be  consulted  at  the  following  website:  http://www.
risafety.com/.
onclusions
MR  is  the  imaging  method  of  choice  for  RV  assess-
ent  in  ACHD  patients  with  rTOF,  Ebstein  anomaly  and
ystemic  RV.  It  can  provide  relatively  accurate  measure-
ents  of  RV  volume  and  function,  and  arterial  ﬂow,
ith  additional  anatomical  information  provided  by  three-
imensional  contrast  angiography  and  late  gadolinium
maging  of  ﬁbrosis.  CMR  visualization  and  measurements
ontribute  to  decision-making  regarding  intervention.  A
edicated  CMR  service  should  be  regarded  as  a  neces-
ary  facility  of  a  centre  specializing  in  the  care  of  ACHD
atients.
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